Compare Hut 8 Corp (HUT) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hut 8 Corp vs Tenet Healthcare Corporation — how do they compare? Hut 8 Corp trades at $82.44 (market cap $11.01B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hut 8 Corp for 11 Days and Tenet Healthcare Corporation for 15 Days on average.
| HUT | THC | |
|---|---|---|
Market Cap | $11.01B | $20.92B |
Volume | 9,892,615 | 455,764 |
Sector | Financials | Health |
52-Week High | $133.02 | $280.77 |
52-Week Low | $33.76 | $161.37 |
Typical Hold Time | 11 Days | 15 Days |
Enterprise Value | $18.45B | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HUT trades at $89.30, down 3.17% today, with a bearish technical signal and negative earnings momentum. The company reported significant losses with a net income margin of -188.59% despite revenue growth projections. Recent developments include a $1.07 billion credit facility expansion and strong analyst support with 93.75% buy ratings and a $156.79 consensus price target, suggesting substantial upside potential from current levels.
While HUT faces fundamental challenges with persistent losses and negative cash flow, the company's strategic pivot to AI infrastructure and substantial contract pipeline ($26.6B in long-term contracts) offers growth potential. Key risks include execution challenges in transitioning from mining operations and competitive pressures in the rapidly evolving AI infrastructure space. The stock presents a high-risk, high-reward opportunity with significant analyst optimism.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
